ECSP13012548A - Inhibidores de oxadiazol de la producción de leucotrienos. - Google Patents

Inhibidores de oxadiazol de la producción de leucotrienos.

Info

Publication number
ECSP13012548A
ECSP13012548A ECSP13012548A ECSP13012548A EC SP13012548 A ECSP13012548 A EC SP13012548A EC SP13012548 A ECSP13012548 A EC SP13012548A EC SP13012548 A ECSP13012548 A EC SP13012548A
Authority
EC
Ecuador
Prior art keywords
leucotrene
oxadiazol
inhibitors
production
compounds
Prior art date
Application number
Other languages
English (en)
Spanish (es)
Inventor
Doris Riether
Renee Zindell
Alexandra Bartolozzi
Weimin Liu
Tina Marie Morwick
Zhidong Chen
Todd Bosanac
Lombaert Stephane De
Heather Tye
John D Dines
Pui Leng Loke
Alan Olague
Lifen Wu
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44720163&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP13012548(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ECSP13012548A publication Critical patent/ECSP13012548A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ECSP13012548 2010-09-23 2013-04-11 Inhibidores de oxadiazol de la producción de leucotrienos. ECSP13012548A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38573310P 2010-09-23 2010-09-23
US201161533349P 2011-09-12 2011-09-12

Publications (1)

Publication Number Publication Date
ECSP13012548A true ECSP13012548A (es) 2013-06-28

Family

ID=44720163

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13012548 ECSP13012548A (es) 2010-09-23 2013-04-11 Inhibidores de oxadiazol de la producción de leucotrienos.

Country Status (19)

Country Link
US (1) US8575201B2 (en])
EP (1) EP2619197B1 (en])
JP (1) JP5713511B2 (en])
KR (1) KR20130109122A (en])
CN (1) CN103261193A (en])
AU (1) AU2011305667A1 (en])
BR (1) BR112013008638A2 (en])
CA (1) CA2812449A1 (en])
CL (1) CL2013000788A1 (en])
CO (1) CO6710902A2 (en])
EA (1) EA201300389A1 (en])
EC (1) ECSP13012548A (en])
IN (1) IN2013DN02555A (en])
MX (1) MX2013003202A (en])
PE (1) PE20131398A1 (en])
PH (1) PH12013500545A1 (en])
SG (1) SG188604A1 (en])
WO (1) WO2012040139A1 (en])
ZA (1) ZA201301747B (en])

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3150164B2 (ja) 1991-05-01 2001-03-26 電気化学工業株式会社 セメント混和材及びセメント組成物
US8580829B2 (en) * 2010-08-26 2013-11-12 Boehringer Ingelheim International Gmbh Oxadiazole inhibitors of leukotriene production
SG188604A1 (en) 2010-09-23 2013-04-30 Boehringer Ingelheim Int Oxadiazole inhibitors of leukotriene production
JP5828188B2 (ja) * 2010-09-23 2015-12-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン産生のオキサジアゾール阻害剤
AR089853A1 (es) 2012-02-01 2014-09-24 Boehringer Ingelheim Int Inhibidores de oxadiazol de la produccion de leucotrienos para terapia de combinacion, composicion farmaceutica, uso
ES2706399T3 (es) * 2013-02-04 2019-03-28 Janssen Pharmaceutica Nv Moduladores de FLAP
PL2875736T3 (pl) 2013-11-26 2017-02-28 Citrage N-karbamoiloputrescyna do zwiększenia syntezy białka mięśni

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2002356A3 (cs) 1999-08-06 2002-06-12 Janssen Pharmaceutica N. V. Deriváty 6-azauracilu inhibující interleukin-5
AU2004283080A1 (en) * 2003-08-13 2005-05-06 Novartis Vaccines And Diagnostics, Inc. GSK-3 inhibitors and uses thereof
US7319108B2 (en) 2004-01-25 2008-01-15 Sanofi-Aventis Deutschland Gmbh Aryl-substituted heterocycles, process for their preparation and their use as medicaments
AU2005295646B2 (en) 2004-10-18 2008-11-20 Merck Sharp & Dohme Corp. Diphenyl substituted alkanes as flap inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) * 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
AU2007238878A1 (en) * 2006-04-11 2007-10-25 Merck Sharp & Dohme Corp. Diaryl substituted alkanes
CA2787343C (en) 2006-06-26 2016-08-02 Amgen Inc. Compositions comprising modified lcat and uses thereof
AU2007293373A1 (en) * 2006-09-01 2008-03-13 Merck Sharp & Dohme Corp. Inhibitors of 5 -lipoxygenase activating protein (FLAP)
US20100120784A1 (en) 2007-04-20 2010-05-13 Lachance Nicolas Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
AU2008266960A1 (en) 2007-06-20 2008-12-24 Merck Sharp & Dohme Corp. Diphenyl substituted alkanes
US20110003815A1 (en) 2007-10-10 2011-01-06 Merck & Co., Inc. Diphenyl substituted cycloalkanes
DE102008037790A1 (de) * 2008-08-14 2010-02-18 Merck Patent Gmbh Bicyclische Triazolderivate
CN102271682B (zh) * 2008-10-31 2015-12-16 默沙东公司 用于治疗疼痛的p2x3受体拮抗剂
TW201040175A (en) 2009-02-04 2010-11-16 Pfizer 4-amino-7,8-dihydropyrido[4,3-d]pyrimidin-5(6H)-one derivatives
AU2011252974A1 (en) 2010-05-12 2012-12-13 Vanderbilt University Heterocyclic sulfone mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
KR20130100105A (ko) * 2010-08-16 2013-09-09 베링거 인겔하임 인터내셔날 게엠베하 류코트리엔 생성 억제제인 옥사디아졸
US8580829B2 (en) * 2010-08-26 2013-11-12 Boehringer Ingelheim International Gmbh Oxadiazole inhibitors of leukotriene production
JP5828188B2 (ja) * 2010-09-23 2015-12-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン産生のオキサジアゾール阻害剤
SG188604A1 (en) 2010-09-23 2013-04-30 Boehringer Ingelheim Int Oxadiazole inhibitors of leukotriene production

Also Published As

Publication number Publication date
PE20131398A1 (es) 2013-12-19
KR20130109122A (ko) 2013-10-07
US20120295896A1 (en) 2012-11-22
EP2619197B1 (en) 2015-08-05
MX2013003202A (es) 2013-04-24
JP5713511B2 (ja) 2015-05-07
EA201300389A1 (ru) 2013-09-30
ZA201301747B (en) 2014-08-27
EP2619197A1 (en) 2013-07-31
PH12013500545A1 (en) 2013-05-06
WO2012040139A1 (en) 2012-03-29
US8575201B2 (en) 2013-11-05
BR112013008638A2 (pt) 2016-06-21
JP2013537909A (ja) 2013-10-07
AU2011305667A1 (en) 2013-03-21
CO6710902A2 (es) 2013-07-15
IN2013DN02555A (en]) 2015-08-07
CA2812449A1 (en) 2012-03-29
CL2013000788A1 (es) 2013-06-28
CN103261193A (zh) 2013-08-21
SG188604A1 (en) 2013-04-30

Similar Documents

Publication Publication Date Title
ECSP13012494A (es) Inhibidores de oxadiazol de la producción de leucotrieno.
ECSP15012804A (es) Alcoxipirazoles como activadores de guanilato ciclasa soluble
CO6771439A2 (es) Inhibidores de benzodioxano de la producción de leucotrieno
PH12015500260A1 (en) Neprilysin inhibitors
MX2017000926A (es) Acidos carboxilicos heterociclicos como activadores de guanilato ciclasa soluble.
NI201400107A (es) Compuestos de heterociclilo como inhibidores de mek
UY34917A (es) Inhibidores de la producción de leucotrieno-a4-hidrolasa (lta4h), composiciones farmacéuticas que los contienen y proceso para su preparación
PH12014502733A1 (en) Neprilysin inhibitors
MY165087A (en) Neprilysin inhibitors
CU20140072A7 (es) Derivados de dihidro-oxazina y dihidro-pirido-oxazina
MX377552B (es) Proceso para preparar un compuesto antiviral de formula i.
DOP2014000036A (es) Compuestos de piridazinona y su uso como inhibidores daao
DOP2014000012A (es) Nuevos compuestos de 4-piperidinilo para uso como inhibidores de la tankirasa
ECSP13012548A (es) Inhibidores de oxadiazol de la producción de leucotrienos.
MX2019003026A (es) Compuestos de heteroarilcarboxamida como inhibidores de ripk2.
UY35551A (es) Derivados heteroarilos como inhibidores de aldosterona sintasa
CO2017003305A2 (es) Derivados de la amida del ácido 2-[piridin-3-il]-2,3-dihidro-benzo[1,4]dioxin-5-carboxílico o del 2-[piridin-3-il]-2,3-dihidro-benzo[1,4]dioxin-5-carbonitrilo como inhibidores de aldosterona sintasa
UY36228A (es) Derivados de heteroarilo como inhibidores de aldosterona sintasa (cyp11b2) y composiciones farmacéuticas que los contienen
TN2013000122A1 (en) Oxadiazole inhibitors of leukotriene production
CU20100127A7 (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
TN2013000052A1 (en) Oxadiazole inhibitors of leukotriene production